GALT
Galectin Therapeutics Inc

10,511
Mkt Cap
$196.02M
Volume
382,200.00
52W High
$7.13
52W Low
$1.12
PE Ratio
-5.06
GALT Fundamentals
Price
$2.99
Prev Close
$3.04
Open
$3.02
50D MA
$4.92
Beta
0.50
Avg. Volume
765,439.09
EPS (Annual)
-$0.7575
P/B
-1.53
Rev/Employee
$0.00
Loading...
Loading...
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
15

Frequently Asked Questions

What is Market Cap of Galectin Therapeutics Inc?
What is the 52-week high for Galectin Therapeutics Inc?
What is the 52-week low for Galectin Therapeutics Inc?
What is Galectin Therapeutics Inc stock price today?
What was Galectin Therapeutics Inc stock price yesterday?
What is the PE ratio of Galectin Therapeutics Inc?
What is the Price-to-Book ratio of Galectin Therapeutics Inc?
What is the 50-day moving average of Galectin Therapeutics Inc?
How many employess does Galectin Therapeutics Inc has?

Latest GALT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.